Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Warfarin does not improve survival in advanced solid tumors; challenges anticoagulation hypotheses for malignancy while extending evidence on progression endpoints.
Zacharski et al. (1984) studied this question.